Comeau AM - Search Results

1

Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency.

Comeau AM, Hale JE, Pai SY, Bonilla FA, Notarangelo LD, Pasternack MS, Meissner HC, Cooper ER, DeMaria A, Sahai I, Eaton RB. Comeau AM, et al. J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S273-81. doi: 10.1007/s10545-010-9103-9. Epub 2010 May 20. J Inherit Metab Dis. 2010. PMID: 20490925

2

Application of the polymerase chain reaction for the detection of HIV in specimens from newborn screening programs.

Comeau AM. Comeau AM. Acta Paediatr Suppl. 1994 Aug;400:29-30. doi: 10.1111/j.1651-2227.1994.tb13330.x. Acta Paediatr Suppl. 1994. PMID: 7833556

3

Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.

Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, Strauss AW, Comeau AM, Eaton RB, Grady GF. Zytkovicz TH, et al. Among authors: comeau am. Clin Chem. 2001 Nov;47(11):1945-55. Clin Chem. 2001. PMID: 11673361

4

Successes of newborn screening programs.

Comeau AM, Eaton RB. Comeau AM, et al. Science. 2002 Jan 4;295(5552):44-5. doi: 10.1126/science.295.5552.44c. Science. 2002. PMID: 11780647 No abstract available.

5

Newborn screening: new developments in a proven field.

Eaton RB, Comeau AM, Zytkovicz TH, Larson C. Eaton RB, et al. Among authors: comeau am. Clin Lab Sci. 2002 Fall;15(4):239-44. Clin Lab Sci. 2002. PMID: 12776784 No abstract available.

6

Integration of new genetic diseases into statewide newborn screening: New England experience.

Comeau AM, Larson C, Eaton RB. Comeau AM, et al. Am J Med Genet C Semin Med Genet. 2004 Feb 15;125C(1):35-41. doi: 10.1002/ajmg.c.30001. Am J Med Genet C Semin Med Genet. 2004. PMID: 14755432

7

Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.

Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB. Comeau AM, et al. Pediatrics. 2004 Jun;113(6):1573-81. doi: 10.1542/peds.113.6.1573. Pediatrics. 2004. PMID: 15173476

8

Sweat testing infants detected by cystic fibrosis newborn screening.

Parad RB, Comeau AM, Dorkin HL, Dovey M, Gerstle R, Martin T, O'Sullivan BP. Parad RB, et al. Among authors: comeau am. J Pediatr. 2005 Sep;147(3 Suppl):S69-72. doi: 10.1016/j.jpeds.2005.08.015. J Pediatr. 2005. PMID: 16202787

9

Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.

Parad RB, Comeau AM. Parad RB, et al. Among authors: comeau am. J Pediatr. 2005 Sep;147(3 Suppl):S78-82. doi: 10.1016/j.jpeds.2005.08.017. J Pediatr. 2005. PMID: 16202789

10

Challenges in implementing a successful newborn cystic fibrosis screening program.

Comeau AM, Parad R, Gerstle R, O'Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB. Comeau AM, et al. J Pediatr. 2005 Sep;147(3 Suppl):S89-93. doi: 10.1016/j.jpeds.2005.08.006. J Pediatr. 2005. PMID: 16202791 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters